BUPA Gears Up For Health Insurance Operation In China
This article was originally published in PharmAsia News
BUPA, the largest U.K. health insurance corporation, has announced its intention to set up shop in China with a local collaborator. It plans to apply for a health insurance license in September next year and is seeking a partner with government background that has a wide distribution network and experience with foreign investors. According to Chinese regulation, foreign insurance companies can operate only in joint ventures, thus it is crucial for BUPA to find a suitable partner. The insurance giant has completed and published a survey on consumer lifestyle, health care, and insurance conducted in Beijing, Shanghai, and Guangzhou. It is also cooperating with several hospitals in health-related programs. (Click here for more)
You may also be interested in...
Mylan and Pfizer’s Upjohn, already facing a delay to their proposed merger, may have to overcome regulatory barriers to get the deal over the line.
National export restrictions on medicines have been slammed by the international off-patent pharmaceutical industry as being “counter-productive” during the coronavirus crisis. The IGBA is instead urging international co-operation and transparency, pointing to a positive example of supply-chain connectivity in the Asia-Pacific region.
Claims circulated on social media that its Cebion supplement could prevent coronavirus has led Italy's Dompé to take legal action.